Back to search

Article

Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and NRF2 Activation

2024-02-29

Abstract excerpt

(1) Background: TNF inhibitors (TNFi) have revolutionized the treatment of rheumatoid arthritis (RA). However, 30-40 % of RA patients do not respond adequately to those biologics. In addition to neutralizing soluble TNF, TNFi have the ability to bind the transmembrane form of TNF, tmTNF. Importantly, tmTNF can act itself as a receptor that induces a “Reverse Signaling” (RS) in cells. We previously showed that cert...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
99a4d54d-25d9-5ce0-9aef-a2b31feef949
DOI
10.20944/preprints202402.1740.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and NRF2 ActivationDOI 10.20944/preprints202402.1740.v1
Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.Semantic proximity
Identification of a novel transcriptome signature for predicting the response to anti-TNF-α treatment in rheumatoid arthritis patientsSemantic proximity
Early Prediction of Clinical Response to Anti-TNF Treatment using Multi-omics and Machine Learning in Rheumatoid ArthritisSemantic proximity
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritisSemantic proximity
Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-α treatmentsSemantic proximity
Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy.Semantic proximity
Integration of Known DNA, RNA and Protein Biomarkers Provides Prediction of Anti-TNF Response in Rheumatoid Arthritis: Results from the COMBINE StudySemantic proximity
Gene expression profile predicting the response to anti-TNF treatment in patients with rheumatoid arthritis; analysis of GEO datasetsSemantic proximity
Gene expression analysis of anti-TNF-treated rheumatoid arthritis patients reveals the links between NADPH oxidase expression profile and immunophenotypic changes in peripheral blood mononuclear cellsSemantic proximity
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritisSemantic proximity
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.Semantic proximity
[Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].Semantic proximity
Select a neighboring publication to make it the new centre.